Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

ORISE Research Fellowship for Advancing CBRN Medical Countermeasures

by Global Biodefense Staff
March 12, 2022
Webcast: Interagency Meeting on Immunology of Protection from Ebola

The Biomedical Advanced Research and Development Authority (BARDA) is seeking students and post-graduate fellows through the Oak Ridge Institute for Science and Education (ORISE) Research Participation Program. This fellowship identifies new talent, bringing in members of the academic community to participate in programs, projects and activities to support BARDA’s mission “to develop and make available medical countermeasures (MCMs) by forming unique public-private partnerships to drive innovation off the bench to the patient to save lives.”

The opportunity currently is open to:

  • Students (Part-time/Term)
  • Post-Graduates (Full-time)

BARDA provides an integrated, systematic approach to the advanced research and development of medical countermeasures for chemical, biological, radiological, nuclear agents, pandemic influenza, and emerging infectious diseases, like COVID-19, that threaten the U.S. civilian population. Fellows will conduct research on projects related to medical countermeasure (MCMs) development, including preclinical model development, non-clinical testing and evaluation, and clinical trials.

Opportunities exist to present the results of these projects at national conferences and have the findings published in peer-reviewed journals. Other opportunities may include providing support to inter-agency working groups, assisting in the development of relevant policy documents, interacting with academic and industry partners, and participating in team communications with the U.S. Food and Drug Administration (FDA), drug developers, Contract Research Organizations (CROs), and National Institute of Health (NIH) all to ensure progress toward BARDA’s mission. 

BARDA is engaged in program management; there will be no bench or wet lab research associated with these opportunities. Virtual presentations or travel for presentations at conferences/meetings may be required pending pandemic related travel restrictions. BARDA anticipates maintaining a largely virtual environment. The appointment is full-time and given our current remote telework posture, 100% telework from remote sites outside of the Washington, D.C. area can be considered. 

Below are specific opportunities for Post-Graduates available at BARDA:

  • Division of CBRN Countermeasures
  • Vaccine Branch
  • Antivirals and Antitoxins Branch
  • Radiological/Nuclear Countermeasures Branch
  • Division of Clinical Development
  • Division of Research, Innovation and Ventures (DRIVe)
  • Frontiers Office/ ENACT Team
  • Launch Office/Infection Severity and Solving Sepsis Team
  • Catalyst Office
  • Alliance Office/ Beyond the Needle & ReDirect Team

Appointment packages include:

  • Monthly stipend
  • Health Insurance Allowance
  • Paid Absences (including maternity)
  • Travel allowance for attendance at conferences and/or meetings

The current application deadline is 30 April 2022. For more details about this opportunity, please visit https://orise.orau.gov/hhs/applicants/BARDA.html

Tags: ASPRBARDAEditor PickHHSOpportunities

Related Posts

DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies
Medical Countermeasures

NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy